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Abstract: Patients frequently do not take medicines as prescribed and often do not communicate 
with their physicians about their medication-taking behavior. The movement for “patient-
centered” care has led to relabeling of this problem from “noncompliance” to “nonadherence” 
and later to a rhetoric of “concordance” and “shared decision making” in which physicians and 
patients are viewed as partners who ideally come to agreement about appropriate treatment. We 
conducted a qualitative content analysis of online comments to a New York Times article on low 
rates of medication adherence. The online discussion provides data about how a highly selected, 
educated sample of patients thinks about medication use and the doctor–patient relationship. Our 
analysis revealed patient empowerment and self-reliance, considerable mistrust of medications 
and medical practice, and frequent noncommunication about medication adherence issues. We 
discuss how these observations can potentially be understood with reference to Habermas’s theory 
of communicative action, and conclude that physicians can benefit from better understanding 
the negative ways in which some patients perceive physicians’ prescribing practices.
Keywords: patient–provider communication, trust, medical decision making, dissent and 
disputes, culture of medicine, health literacy
Introduction
Between 30% and 60% of patients with chronic illnesses are not adherent to medical 
therapy, which can be both dangerous and costly, leading to hospitalization, adverse 
effects, and disease progression.1 Whereas nonadherence is often thought of as failure 
to take medications consistently, a 2010 study of e-prescriptions reported that 22% were 
never even filled once,2 with primary nonadherence rates of 28.4% for hypertension 
medications, 28.2% for hyperlipidemia medications, and 31.4% for diabetes medications. 
To make matters worse, physicians and patients often do not communicate about 
medication nonadherence.3 Known reasons for this nonadherence include concerns about 
adverse effects; worries about dependence, tolerance, and addiction; the potential harm 
from taking medicines on a long-term basis; and the possibility of medicines masking 
other symptoms.4 Medicines may present problems pertaining to disclosure and stigma. 
Some patients modify their regimens to minimize their intake of medicines, while some 
use nonpharmacologic treatments to either supplant or supplement their medicines. 
Patients often do not discuss these changes with their doctors.5,6
The literature suggests diverse reasons for this lack of discussion. Patients keeping 
silent about their doubts could be demonstrating deference to doctors,7 or, alternatively, 
patients may fear provoking anger in the provider by admitting nonadherence.8 
Questioning the provider risks creating tension.7,9 One study found that patients were 
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much less likely to take medication if beliefs and concerns 
that conflicted with their physicians’ beliefs were not 
addressed.10
Meanwhile, patient participation in the medical encounter 
is widely thought to have measureable benefits to patients.11–13 
While until the mid-twentieth century a model of “benevolent 
paternalism,”14,15 where the patient’s role was to trust and 
to follow “doctor’s orders,” prevailed, a “patient-centered” 
care movement has more recently taken hold. Lipkin et al16 
defined “patient centered” in 1984 as treating the patient “as 
a unique person with his [sic] own story to tell (p. 277)”. As 
part of this normative shift, the term “noncompliance”, which 
was seen as presuming a duty of obedience, was replaced 
by “nonadherence.”
An increased interest in “shared decision making”17 and 
“concordance”18 models since the late 1990s represents an 
effort to redefine the clinical relationship. The new models 
center on physicians and patients reaching agreement – via 
discussion that includes and respects the beliefs and wishes of 
the patient – about whether, when, and how medicines are to 
be taken.19 Cushing and Metcalfe20 emphasize the importance 
of two-way communication in achieving concordance: “The 
challenge here is for the professional to delve beneath the 
surface of … deference to ensure that important issues which 
might affect adherence are not being ignored.” In the concor-
dance model, the patient knows his or her views are respected 
and any subsequent difficulties the patient has with treatment 
can be discussed. This prevents the patient from being in the 
uncomfortable position of either telling the doctor that he or 
she has not followed their advice or, alternatively, of lying. 
However, Cushing and Metcalfe20 conclude that changes in 
the patient provider dynamic have tended to be superficial 
and have failed to create real partnership.
The interest in shared-decision models comes at a time 
of major change in society’s access to information about 
prescription medications. The Internet has given patients 
access to information that was once available only to health 
care professionals.21 Muir Gray suggests this access may lead 
to stronger doctor–patient relationships. However, access 
to health information also increases awareness of clinical 
uncertainty and differences of opinion about treatment, which 
can result in a decline in deference toward and trust of the 
medical profession.22
To better understand how physicians and patients are 
constructing the concept of concordance as they discuss 
adherence to prescription medications, we examined data 
from an online discussion that focused on these issues. We 
hypothesized that the postings of a self-selected group of 
New York Times readers about medication adherence and 
physician–patient communication about medication adher-
ence would provide unique insights into concordance about 
prescription medications.
Methods
We conducted a qualitative content analysis of online 
  comments responding to an article published in the New York 
Times in 2010: “When patients don’t fill their prescriptions,” 
by Dr Pauline W Chen.23 The article reviewed a recently 
published paper by Fischer et al2 that used e-prescribing data 
to quantify rates of primary nonadherence (ie, not filling 
a prescription in the first place). Chen23 described Fischer 
et al’s2 findings, as well as those of other papers reporting 
similar findings, and speculated about patients’ reluctance 
to admit nonadherence: “Bringing the topic up in the exam 
room feels more like a confession or inquisition than a 
rational discussion. Few of us want to talk about medication 
nonadherence, much less admit to it.”23
As with all columns in the “Doctor and Patient” section 
of the New York Times online, a public comment section 
was available at the time Chen’s23 article appeared. The 
article was published on May 20, 2010, and comments were 
submitted from this date until October 27, 2010, with most 
posts occurring within days of the original publication. Our 
analysis is based on a complete retrieval of all comments 
made to the article as of October 27, 2010. By October 27, 
2010, there were 130 comments posted by 117 unique users. 
Because of our interest in patient views, we excluded from 
analysis 21 comments from people who identified themselves 
as health care providers – including physicians, nurses, and 
pharmacists – in the body of their comments or in their 
signatures. The analysis was limited to comments in which 
people discussed their own beliefs, attitudes, and behaviors, 
rather than attributing attitudes and beliefs to others. Other 
than moderating comments to ensure they are on-topic, 
noncommercial, legal, and not abusive, the New York Times 
encourages a full range of opinion.24
Anyone could comment: a subscription to the New York 
Times was not required. We cannot know anything about the 
demographic or socioeconomic characteristics of individual 
commenters, except for whatever internal evidence there 
may be in their contributions. New York Times readers 
are, on average, better educated and more affluent than 
the general public. According to survey data posted on the 
newspaper’s Website, 88% of daily New York Times readers 
have a college degree, and readers have a median household 
income of $168,400.25 We received an opinion from the 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
12
Bezreh et alPatient Preference and Adherence 2012:6
Brown University Institutional Review Board that use of 
these publicly available data does not constitute human 
subjects research.
Use of online data for research purposes is increasing. 
A recent study found that Web forum discussions provided 
excellent insights into day-to-day concerns of people going 
through an experience, and that they are valuable for exploring 
sensitive subjects. In comparison with in-person interviews, 
online comments were less concerned with “presentation of 
a moral front characterizing an acceptable ‘self’.”26
Four members of the research team reviewed the data 
independently, in its entirety, and agreed on a general 
approach including the criteria for inclusion and broad 
categories of interest. Categories emerged from the data 
inductively. One member of the team (TB) then developed 
specific codes using ATLAS.ti® software (v 6; Scientific 
Software Development GmbH, Berlin) to classify themes 
encountered in the data. Members of the research team then 
discussed these themes. At this stage we recognized that the 
framework of concordance/discordance was highly salient in 
the data and we allowed it to guide our interpretation. Two 
team members (TB and MBL) then worked iteratively to 
refine the interpretation and presentation, followed by final 
discussion and agreement among all of the authors.
Qualitative content analysis examines language intensely 
for the purpose of classifying large amounts of text into 
an efficient number of categories that represent similar 
meanings.27 We applied what Hsieh and Shannon28 call 
“conventional content analysis,” a method used to describe 
and summarize a data set. The comments often referenced 
and sometimes responded to previous posts, and aside 
from a few threads where people posted “me too!” – style 
comments, we found new contributions were additive. 
Therefore, we exercised caution in assessing the weight 
of any theme or opinion by the number of times it was 
mentioned.
Results
One hundred and thirty unique comments were included in 
the analysis. Responses overwhelmingly addressed reasons 
for the high rates of nonadherence mentioned in the article. 
Rather than seeing nonadherence as a failure, most comment-
ers defended or explained nonadherence as a reasonable or 
justifiable decision, often one the commenters had themselves 
made. We identified several themes: (1) mistrust and criti-
cism of health care institutions; (2) patients shifting their 
strategies; and (3) patients not wanting to discuss adherence 
with their physicians.
Mistrust and criticism of health  
care institutions
Many commenters (n = 33) expressed distrust of the pharma-
ceutical industry, prescription medications, and the culture 
of medication prescription. Commenters noted the well-
publicized instances in which approved pharmaceuticals had 
been found to be ineffective, dangerous, or overpromoted, 
such as thalidomide causing birth defects, recent studies 
calling into question the widespread prescribing of statins 
to people at low risk for coronary heart disease, and the 
initial enthusiasm for selective serotonin reuptake inhibi-
tors followed by increasing evidence that they are of limited 
value for most depression sufferers.29 Or, as one commenter 
put it, “a waste of time an[d] money for the overwhelming 
majority.” Commenters specifically noted distrust of the 
US Food and Drug Administration (FDA) drug approval 
system: “Fast-tracked through the FDA with sorely limited 
and cherry-picked trials? No thanks.” In light of this distrust, 
doctors’ enthusiasm for new drugs can appear misplaced: 
“That doctors have become shills for pills they often do 
not fully understand is surely part of the reason why caveat 
emptor sneaks into the medicine world.”
Many commenters (n = 24) criticized pharmaceutically 
oriented medical practice. Doctors were described as overeager 
to write prescriptions, writing “too many” prescriptions “at 
whim,” “without listening,” “for no reason,” as if “throwing 
the pills at a problem is the automatic answer.” Doctors were 
characterized as “out of control” in their prescribing; “[I]t’s a 
risk to even mention a ‘symptom’ because most people know 
they’ll just get another drug!” One commenter concluded that 
her doctor was using a prescription as a cheaper alternative to 
surgery and as a strategy “just to get rid of patients or in the 
hopes that patients will stop asking questions and leave.” (We 
base gender assignment on the signatures commenters used.) 
Doctors were characterized as being excessively influenced 
by pharmaceutical marketing; as one respondent put it, 
“Pharma Reps … pump up the volume with hype.” Several 
commenters believed prescribing is in the financial interest 
of physicians. One referred to the doctor’s “commission” on 
filled prescriptions. Another wrote, “Always keep in mind that 
in the doctor’s world, his children’s tuition payments come first 
… then the mortgage payment, assuming he has paid off his 
student loans, then the payments on his Mercedes.”
A few comments (n = 9) bemoaned the focus on medi-
cation instead of lifestyle alternatives: “I am surrounded 
by diabetics who eat the most dreadful diets imaginable 
and barely move their bodies” and “I’m stunned that they 
really believe the pills give cover for their woeful habits.” 
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For   lifestyle diseases, one commenter was perplexed that 
someone would choose pills over lifestyle changes:
What I can’t and don’t understand is why on earth would 
someone prefer taking a pill – or pills, and usually expensive 
ones with very unpleasant side effects – to making truly 
enjoyable and simple lifestyle changes? Why? Is this the 
American way now?
Other commenters wrote that medication prescription has 
become commodified and that patients are under pressure 
to be good consumers. The first commenter, who signed 
her name “Noncompliant Nancy,” wrote, “Can’t be a good 
American and not be on pills of some sort, which I suppose 
is a natural consequence of good old Living Better Through 
Chemistry.” Whether taking medicine was characterized as a 
lazy alternative to lifestyle changes or as a complicit embrace 
of a commodified health care system, adherence was often 
stigmatized. Posts contained suggestions like “Throw out the 
pills.” But there was also dissent: 14   commenters wrote in 
defense of or in praise of medications. For example, “Medica-
tions have a place in our lives and have helped many people. 
Not all medications are bad,” or “Look, I don’t like taking 
2 pills a day for high BP [blood pressure] but it works.” 
One commenter characterized comments stigmatizing phar-
maceuticals contemptuously: “Sometimes the attitude of 
these high-and-mighty-Michael Pollan-spouting-no-carbon-
footprint-I-only-feed-my-kid-lentils-don’t-watch-television-
or-drive-a-car posters really get to me.”
Abstract and case-specific defenses of medications not-
withstanding, disenchantment extended to the entire system: 
“[I]t’s my conviction that we have a broken system of health 
care,” “Thanks, health care bill, for nothing,” and “The way 
we handle health care in the US is beyond stupid, wasteful, 
dangerous and designed more for increased corporate profits 
than a reasonable quality of health care for all of those who 
want it.” Two posts bemoaned the fragmentation of the US 
system, one concluded that “too much is scattered across too 
many for any reasonable person to ensure that the right things 
get done for the right reasons most of the time.”   Additionally, 
several posts complained of doctors not taking enough time 
with their patients. One warned against “doctor-bots, blithely 
following ‘protocols.’”
The insurance industry was often singled out for 
criticism. Insurers were said to make unethical deals with 
drug companies, fixing which drugs to put on formularies, 
such as one commenter who reported being forced to take 
Risperdal® instead of Abilify®. The commenter demanded, 
“I want to know how the insurance company can ‘prescribe’ 
your medication! It is not even on the FDA site as being 
  comparable!” Insurance companies were said to contribute 
to the adherence problem through high co-pays, insistence on 
generics when there is no generic, having to make   multiple 
requests to get even “maintenance” drugs covered, rapidly 
increasing premiums, refusing payment for some medications 
and regulating certain medicines as “top tier”. One commenter 
concluded, “All that counts is the money saved.” Twelve 
posts cited cost as a barrier to adherence for them personally. 
Twenty more assumed cost was a barrier in the abstract.
Patients shifting their strategies
Commenters expressed the belief that the onus is on them to 
compensate for these health care problems:
Dr Welby is obsolete. No time, must hurry, get a test, leave, 
get out. So then we see what scraps we can find … on the 
internet … then, decide … Patients want to at least be their 
own consultant.
Commenters described researching each new prescrip-
tion on the Internet and catching contraindicated medicines; 
“Doctors shouldn’t be quite so astonished or dismayed that 
their patients take their medicinal edicts with the grain of salt 
once they’ve had a bad experience.” One patient, who com-
plained that her various doctors do not adequately interview 
her or consult with one another, wrote, “If I didn’t keep a 
medical notebook and if I wasn’t educated, I wonder if there 
would be any kind of congruency in my care.”
The posts demonstrated that commenters believed they 
had high health literacy. One concluded that doctors must 
be “too busy to do meaningful research on efficacy, drug 
reaction, etc.” Commenters had access to a great deal of 
information and to the latest research, and they indicated 
that they used it to calculate their own risks. For example, 
one commenter refused an immunosuppressant for ulcerative 
colitis because, by her calculation, her risk for colon cancer 
is only “1% higher … than the rest of the population.” (The 
authors do not assess the accuracy of her reasoning.)
Commenters used assertive language, emphasizing their 
own empowerment, such as “I REFUSE”, “I said ‘no’ … and 
am glad”, “I have decided”, “I’ve switched doctors”, “I had 
enough and went off the medication”, and “I am the one in 
charge.” In response to the phrase used in the article, one com-
menter wrote, “The term ‘noncompliant’ is telling. A treatment 
plan is not an order given by an all-powerful doctor to a submis-
sive, grateful patient.” Another commenter agreed: “we need 
to stop calling it ‘noncompliance.’ I’m not your charge. I can 
choose to do whatever I want.” Some commenters advocated 
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changing doctors: “If you go to a doctor who seems to always 
prescribe you medication, which you don’t want to take, then 
you should find another doctor, one who shares your views or 
is at least sympathetic to them,” and “If you do not like the 
recommendation of your doctor, talk to him/her regarding 
alternatives. If they have none, consider another doctor.”
Some of these patients had already taken on the role 
of primary decision maker. Reacting to the surprise about 
nonadherence expressed in the article, one commenter wrote, 
“Noncompliance with a doctor’s advice, regarding taking 
medications, seems like it ought to be an expected outcome, 
not surprising.” Automatically following doctor’s orders was 
presented as outdated:
There was a time – let’s see, was it when Eisenhower was 
President? – that a doctor gave you a prescription and you 
had it filled. Then came the proliferation of specialists and 
myriads of drugs, some miraculous, some monstrous.
When patients think of themselves as their own primary 
caregiver, doctors’ roles become advisory rather than 
paternalistic:
Adults have agency and can decide for themselves whether 
the advice they’ve received makes sense and is fit for 
them … In other fields, people use consultants all the time 
whose advice they blatantly ignore, when the advice doesn’t 
fit with their worldview …  .
Some comments revealed a patient who took respon-
sibility for communicating this relational preference to 
physicians:
I’m well educated and assertive and will demand that doc-
tors listen to all my concerns and explain all possible side 
effects of a medication or treatment before we reach an 
agreement together on whether or not to use that treatment 
or medication.
Another writes, “Physicians seem to have a much lower 
threshold for finding drugs worthwhile tha[n] I do. That’s 
OK as long as we understand each other.” However, others 
revealed that they didn’t share their decision making with 
their doctors.
When my doctor prescribes antibiotics without doing a cul-
ture, I don’t fill the prescription … not filling the prescription 
is easier than arguing.
Commenters expressed a great deal of confidence in their 
own research, and in their own assessments about whether to 
follow their physician’s advice about medication taking.
When patients’ certainty directly conflicts with what is 
traditionally the doctor’s domain (applying medical protocol, 
assessing risk, providing expertise), it may be difficult to 
communicate a difference of opinion without undermining the 
status of the doctor. The collapse of status difference between 
doctors and patients became explicit in a heated exchange that 
erupted over the use of the phrase “busy doctors.” The phrase 
was condemned as an excuse “as if that explains or forgives 
a multitude of shortcomings in the delivery of care.” One 
post celebrated the pushback against the phrase that seems 
to summarize “the pervasive physician-as-ultra-special-case 
mindset.” Another post added, “Of course physicians are 
busy. Anybody who does serious work is busy and also 
has spent gobs of money on education and equipment.” In 
this comment forum, the status of physicians was readily 
challenged: “Hey – who isn’t busy? I’m really, really busy 
today because it took me 3 hours to spend 15 minutes with 
my doctor – and at a time of her choosing.”
Patients not wanting to discuss 
adherence with their physicians
Three commenters admitted to not talking with their   doctors 
about their nonadherence, but they did not describe their rea-
sons for their silence. A fourth named cost as part of the barrier 
to disclosure: “Did I want to tell my doctor I couldn’t afford 
it – especially when I didn’t believe I truly needed it?”
Several commenters suggested strategies for doctors to 
improve communication. These included asking about cost, 
asking about compliance, and anticipating and troubleshooting 
problems ahead of time. Strategies for improving the patient 
side of communication also abounded, mainly encouraging 
patient assertiveness: “Ask questions, seek alternatives, be 
realistic, but don’t ignore your health.” Patients were encour-
aged to inform themselves, ask about alternatives, and share 
concerns about side effects. They were reminded, “you need to 
make sure you and your doctor are on the same page.” Several 
posts provided testimonials of successful communication: “in 
my experience, doctors are more than willing to work with 
you to alter a prescription to come up with a more affordable 
option.” Posts about not disclosing nonadherence or disagree-
ments assumed “people do not feel comfortable challenging 
their doctors or asking questions.” One scolded, “Honestly, 
the behavior … reminds me of when I was a kid and I’d lie 
to the dentist about how often I brushed my teeth.”
Discussion
Two main themes emerged from our analysis. The first 
was criticism and distrust of various elements of the health 
care system including pharmaceutical companies, the FDA, 
the drug development process, pharmaceutically oriented 
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medical practice, physicians’ financial incentives and 
motivations, insurance company practices and affordability 
of medications. The second was a shift in the patient role 
toward self-reliance and self-protection.
One way to think about this shift in patient roles is 
via Habermas’s theory of “communicative action,” as 
Stevenson and Scambler30 did in their discussion of the 
concept of “concordance.” Habermas31 makes a useful 
distinction between strategic and communicative action. 
Communicative action is oriented toward “reaching 
understanding,” and, ideally, is free of coercion. In strategic 
action, speakers are less interested in mutual understanding 
and more focused on achieving individual goals. Strategic 
action succeeds to the extent that the actors achieve 
their individual goals, whereas communicative action 
succeeds insofar as the actors freely agree that their goal 
(or goals) is reasonable and merits cooperative behavior. 
Communicative action is thus an inherently consensual 
form of social coordination that describes the core ideal 
of concordance.
Communicative action is characteristic of and genera-
tive of the “lifeworld,” the universe of culturally grounded 
shared understandings in which people interact with and 
make mutual accommodations with their neighbors. For 
Habermas, the lifeworld is “colonized” by bureaucratic 
systems and interests, such as industries and markets, 
which practice “strategic” communication in pursuit of 
pre-established goals, resulting in systematic distortion 
of communication. For example, some might argue that 
drug companies are not as interested in reaching a shared 
understanding with potential customers as they are in 
persuading them to take pills. Habermas thus imports 
speech act theory into an analysis of institutional power 
relationships by recognizing the essential role of trust in 
the production of perlocutionary force and the interpreta-
tion of speech acts.
The physician, in representing the medical profession 
while engaging with individual patients as particular persons, 
is squeezed between powerful health care institutions (“The 
System”) and patients’ lifeworlds. The forum commenters 
in the current analysis frequently described physicians as 
(at least in some cases) untrustworthy because they appeared 
to be engaged in strategic action on behalf of drug companies 
and the health care institution, rather than being engaged 
in communicative action in pursuit of understanding and 
consensus with their patients. The well-publicized scandals 
about drug companies withholding unfavorable findings 
from publication,32 paying for ghostwritten articles,33 and the 
influence of drug manufacturers on physicians34 make such 
distrust seem understandable.
Implicit in many of the posts is an important redefinition 
of the traditional physician–patient relationship. Some 
patients feel the onus is on them to double-check doctor 
recommendations, perform their own research, or decide 
how to make their care congruent with other demands of life 
including financial pressures. Others take this even further 
and appear to be using doctors as “consultants” whose advice 
they may ignore. Furthermore, it appears that these older 
models of how the physician and patient should interact are 
sometimes being replaced without explicit discussion and 
recognition that this is happening.
Habermas’s conceptual framework may help us 
understand these role changes. Previous research has 
noted how the professional status of doctors is reinforced 
by patient deference and by avoiding open disagreement 
and conflict.35,36 This fits within the long-noted tendency of 
politeness to prevail in asymmetric power relationships.37 
Patients’ criticism of the medical system may be difficult 
to bring up in polite exchange. Indeed, if there is a 
preoccupation with holding up a norm of politeness and 
deference while covertly mistrusting the system and the 
doctor, then communicative action is impossible. Only 
strategic action can get the parties through the visit 
comfortably.
Patients who challenge the status of their doctor in 
their own minds may be avoiding conflict on two levels: 
(1) withholding their medical concerns and (2) withholding 
their preferences for a different model of physician–patient 
relationship. Defending one’s own research conclusions and 
expert status without being explicitly invited by the provider 
would upend the “physician expert” model. Complaining 
about being made to wait because one feels one’s time is as 
valuable as a doctor’s time challenges traditional norms in 
a different way. It is difficult to imagine how a patient who 
vehemently critiques commonplace medical assumptions and 
speaks of doctors as naïve participants in a broken system, as 
some of these comments suggest, would voice these views 
with the very practitioners about whom they seem to hold 
such low opinions. Doctors would not only have to solicit 
patient input but also prove that they can accept this level of 
patient criticism amicably.
Furthermore, Stevenson and Scambler30 suggest the 
emphasis on patient-centered care may in itself create a 
barrier to open communication:
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The movement towards mutuality and reciprocity … means 
open strategic action has become less acceptable. It may 
have been replaced by concealed strategic action. Concealed 
strategic action incorporates not only conscious decep-
tion or manipulation but also unconscious deception or 
systematically distorted communications.
We know that discussing nonadherence can be a delicate 
matter. In research specific to human immunodeficiency virus 
care, physicians have been described as lecturing or scolding 
patients about adherence,38 and some patients have reported 
concealing their nonadherent behavior at future visits or even, 
in some cases, discontinuing clinic attendance or stopping 
medication taking altogether as a result.38,39 Forcing the topic 
into the open is probably not sufficient to improve the quality 
of doctor–patient discussion of nonadherence.
Whereas the focus of this article is physician–patient 
communication about medication adherence, not about the 
outcomes or consequences of medication-taking decisions, 
we would be remiss not to comment on the medical risks for 
patients and the legal risks for physicians that dysfunctional 
communication can engender. The dismissive attitude that 
some commenters expressed about physicians’ interest, 
expertise, and caring could easily lead to errors and injury if 
beneficial medications are forgone, harmful ones are taken, or 
dangerous combinations are used. It is hard enough to provide 
high-quality, safe pharmacologic care to patients, particularly 
those using multiple medications, when communication is 
good.40 When communication is poor, the risks for adverse 
patient outcomes increase.41 For concordance about prescrip-
tion medications to be achieved, both patients and physicians 
need to take responsibility for ensuring that communication 
about prescription medications is open, honest, informative, 
and bidirectional.
One limitation of this study is the found nature of the data 
set. We could not interrogate participating voices to clarify 
the meaning of their posts, or follow up with them to elabo-
rate on their thinking. A second limitation is that we do not 
have demographic data about the people who commented, 
only general information about New York Times readers. 
Finally, it is possible that the people who were motivated 
to comment felt provoked by some aspect of the article or 
other comments, creating a selection bias toward people who 
have negative feelings toward doctors or medicine. As we 
were interested in identifying barriers to concordance, this 
bias was found informative, but these views should not be 
interpreted as being generalizable. A review article concluded 
that despite increasing access to the Internet and other societal 
changes, patients still prefer to discuss medications with their 
usual doctor and that they value their relationship with their 
doctors.42 A recent national survey showed that patients trust 
physicians more than other providers and information sources 
for information about medication efficacy, and are second 
only to pharmacists as an information source about medica-
tion costs.43 These caveats notwithstanding, this analysis 
brings to light barriers to concordance that providers treating 
highly informed patients should be prepared for.
Conclusion
Distrust of physicians’ recommendations about medications 
may be more widespread than physicians appreciate, 
particularly among well-educated patients, but this distrust 
is not always expressed. Practitioners may benefit from 
encouraging their patients to express dissent and even mistrust 
about medications and medical practice. It may be necessary 
to invite shared decision-making overtly and to encourage 
disclosure of opinions that may be perceived as taboo or 
threatening. Concordance about prescription medications is 
a worthy goal, but one that may be more difficult to realize 
than many, including patients and physicians, expect.
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